Abuja, Nigeria (CU)_ Nigeria-based pharmaceuticals Emzor has inked a deal with Mangalam Drugs & Organics Limited in India to manufacture and sell active pharmaceutical ingredients (APIs) in Nigeria for the treatment and prevention of malaria. An API technology transfer and license agreement is included in the deal, which provides a co-development foundation for producing four APIs for malaria therapy, which remains a significant cause of mortality in the African continent.
According to the company’s statement, this will result in the establishment of…
